Long-Term Low-Intervention SafEty and Clinical Outcomes Clinical Study of LivmArli® in Patients With Alagille Syndrome or Progressive Familial Intrahepatic Cholestasis in the European Union (LEAP-EU) | MicrobiomeTrials
Long-Term Low-Intervention SafEty and Clinical Outcomes Clinical Study of LivmArli® in Patients With Alagille Syndrome or Progressive Familial Intrahepatic Cholestasis in the European Union (LEAP-EU)
RecruitingPHASE4INTERVENTIONAL
Trial Details
Start: 2025-09-25Est. Completion: 2030-09-22
Enrollment target: 230 participants
Locations
Cliniques Universitaires Saint Luc (UCLouvain), Brussels, Belgium
University Hospital Gent (UZ Gent), Ghent, Belgium
Hospices Civils de Lyon - Hopital Femme Mère Enfant, Bron, Auvergne-Rhône-Alpes, France
CHU de Toulouse - Hôpital des Enfants, Toulouse, Occitanie, France
Bicetre University Hospital, Le Kremlin-Bicêtre, Île-de-France Region, France
Charite Berlin, Berlin, Germany
Children's University Hospital Essen, Essen, Germany
University Hospital Hamburg-Eppendorf, Hamburg, Germany
2nd Paediatric Clinic P &A Kyriakou Children's Hospital, Athens, Greece
AO Ospedale PAPA GIOVANNI XXIII, Bergamo, Lombardy, Italy
Istituto mediterraneo trapianti - ISMETT, Palermo, Sicily, Italy
University Medical Center Groningen (UMCG), Groningen, Netherlands
Unidade Local de Saude de Coimbra Paediatric Department Avenida Afonso Romăo, Coimbra, Portugal